Gastrointestinal manifestations associated with systemic lupus erythematosus

European Journal of Medical Research

Volumn 11, Issue 6, 2006, Pages 253-260

  Witt, M ^a   Zecher, D ^a   Anders, H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Gastrointerstinal; Intestinal vasculitis; Systemic lupus erythematosus; Therapy

Indexed keywords

ACICLOVIR; ALENDRONIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; CHLORHEXIDINE; CLOBETASOL; CLOFAZIMINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DEXAMETHASONE; FLUCONAZOLE; FLUOCINONIDE; FOSCARNET; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; PHOSPHOLIPID ANTIBODY; PILOCARPINE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; STEROID; THALIDOMIDE; TRIAMCINOLONE;

ABDOMINAL PAIN; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; ECHOGRAPHY; ESOPHAGUS CANDIDIASIS; FATTY LIVER; FLUID THERAPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HEPATITIS; HERPES SIMPLEX; HUMAN; INFECTIOUS DIARRHEA; INFLAMMATION; LICHENOID ERUPTION; LIVER TOXICITY; MUCOSA INFLAMMATION; PANCREATITIS; PEPTIC ULCER; RISK FACTOR; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; THRUSH; TISSUE INJURY; ULCERATIVE ESOPHAGITIS; VASCULITIS;

DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 33746167721     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Kim JK, Ha HK, Byun JY, et al. CT differentiation of mesenteric ischemia due to vasculitis and thromboembolic disease. J Comput Assist Tomogr. 2001; 25:604-11.
2. Lee CK, Ahn MS, Lee EY, et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis. 2002; 61: 547-50.
3. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 1999; 38:917-32.
4. Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus - a clinical, histopathological and immunopathological study. J Rheumatol. 1984; 11:38-42.
5. Karjalainen TK, Tomich CE. A histopathologic study of oral mucosal lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1989; 67:547-54.
6. Orteu CH, Buchanan JA, Hutchison I, Leigh IM, Bull RH. Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? Br J Dermatol. 2001; 144:1219-23
7. Togliatto M, Carrozzo M, Conrotto D, Pagano M, Gandolfo S. Oral lupus erythematosus. Description and analysis of 11 cases Minerva Stomatol. 2000; 49:35-40.
8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271-7.
9. Chua S, Dodd H, Saeed IT, Chakravarty K. Dysphagia in a patient with lupus and review of the literature. Lupus. 2002; 11:322-4.
10. Urman JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum. 1978; 21:58-61.
11. Brennan MT, Valerin MA, Napenas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dent Clin North Am. 2005; 49:127-41,
12. Vitali C, Doria A, Tincani A, et al. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol. 1996; 14 Suppl 16:S17-22.
13. Thompson DF, Skaehill PA. Drug-induced lichen planus. Pharmacotherapy. 1994; 14:561-71.
14. Vitali C, Brey R, Tincani A, Doria A, Bombardieri S. International survey on the management of lupus patients with mucocutaneous (MC), central nervous system (CNS) and renal (R) involvement. Its extension from European (Eu) to American (Am) lupus centres. Lupus 1998; 7(suppl.1): 68.
15. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996 7; 335:1424-30.
16. Luce EB, Montgomery MT, Redding SW. The prevalence of cardiac valvular pathosis in patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1990; 70:590-2.
17. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993; 36:340-7.
18. Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjogren's syndrome in systemic lupus erythematosus. J Rheumatol. 1990; 17:201-4.
19. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcon-Segovia D, Kraus A. Oral manifestations in patients with Sjogrens syndrome. J Rheumatol. 1998; 25:906-10.
20. Rhodus NL. An update on the management for the dental patient with Sjogren's syndrome and xerostomia. Northwest Dent. 1999; 78:27-34.
21. Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence Int. 2004; 35:392-6.
22. Rhodus NL. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjogren's syndrome. Oral Dis. 1997; 3:93-8.
23. Rosas J, Ramos-Casals M, Ena J, et al. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjogren's syndrome. Correlation with clinical, immunological and histological features. Rheumatology (Oxford). 2002; 41:670-5.
24. Schiodt M, Halberg P, Hentzer B. A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg. 1978; 7:83-94.
25. Harvey A, Shulman L, Tumulty P, Conley C, Schonrich E. Systemic lupus etythematosus: review of the literature and clinical analysis of 138 cases. Medicine 154; 33 291-437.
26. Castrucci G, Alimandi L, Fichera A, Altomonte L, Zoli A. Changes in esophageal motility in patients with systemic lupus erythematosus: an esophago-manometric study] Minerva Dietol Gastroenterol. 1990; 36:3-7.
27. Lapadula G, Muolo P, Semeraro F, et al. Esophageal motility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol. 1994; 12:515-21.
28. Ramirez-Mata M, Reyes PA, Alarcon-Segovia D, Garza R. Esophageal motility in systemic lupus erythematosus. Am J Dig Dis. 1974; 19:132-6.
29. Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med. 1997; 103:100-5.
30. al-Hakeem MS, McMillen MA. Evaluation of abdominal pain in systemic lupus erythemarosus. Am J Surg. 1998; 176:291-4.
31. Kalman DR, Khan A, Romain PL, Nompleggi DJ. Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroentetol. 1996; 91:1244-7.
32. Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med. 1982;73:525-31.
33. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus. 1997; 6:235-42.
34. Alcocer-Gouyonnet F, Chan-Nunez C, Hernandez J, Guzman J, Gamboa-Dominguez A. Acute abdomen and lupus enteritis: thrombocytopenia and pneumatosis intestinalis as indicators for surgery. Am Surg. 2000; 66:193-5.
35. Lian TY, Edwards CJ, Chan SP, Chang HH. Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital. Lupus. 2003; 12:612-6.
36. Hallegua DS, in Wallace DJ & Hahn BH, Dubois Lupus Erythematosus, 6th Edn. Baltimore: Willians and Wilkin, 2000, pp. 843-861
37. Weinstein PJ, Noyer CM. Rapid onset of massive ascites as the initial presentation of systemic lupus erythematosus. Am J Gastroenterol. 2000; 95:302-3.
38. Averbuch M, Levo Y. Longstanding intractable ascites as the initial and predominant manifestation of systemic lupus erythematosus. J Rheumatol. 1986; 13:442-3.
39. Ito H, Nanamiya W, Kuroda N, et al. Chronic lupus peritonitis with massive ascites at elderly onset: case report and review of the literature. Intern Med. 2002; 41:1056-61.
40. Andoh A, Fujiyama Y, Kitamura S, et al. Acute lupus peritonitis successfully treated with steroid pulse therapy. J Gastroenterol. 1997; 32:654-7.
41. Provenzano G, Rinaldi F, Le Moli S, Pagliaro L. Chronic lupus peritonitis responsive to treatment with cyclophosphamide. Br J Rheumatol. 1993; 32:1116.
42. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37:187-92.
43. Passam FH, Diamantis ID, Perisinaki G, et al. Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum. 2004; 34:431-41.
44. Ko SF, Lee TY, Cheng TT, et al. CT findings at lupus mesenteric vasculitis. Acta Radiol. 1997; 38:115-20.
45. Byun JY, Ha HK, Yu SY, et al. CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology. 1999; 211:203-9.
46. Kaneko Y, Hirakata M, Suwa A, et al. Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis. Clin Rheumatol. 2004; 23:351-4.
47. Chung HV, Ramji A, Davis JE, et al. Abdominal pain as the initial and sole clinical presenting feature of systemic lupus erythematosus. Can J Gastroenterol. 2003; 17:111-3.
48. Grimbacher B, Huber M, von Kempis J, et al. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol. 1998; 37:1023-8.
49. Kamimura T, Mimori A, Takeda A, et al. Acute acalculous cholecystitis in systemic lupus erythematosus: a case report and review of the literature. Lupus. 1998; 7:361-3.
50. Shin SJ, Na KS, Jung SS, et al. Acute acalculous cholecystitis associated with systemic lupus erythematosus with Sjogren's syndrome. Korean J Intern Med. 2002; 17:61-4.
51. Blaauw AA, Tobe TJ, Derksen RW, Bijlsma JW. A patient with systemic lupus erythematosus and Salmonella enteritidis bacteraemia complicated by rhabdomyolysis and acute cholecystitis. Rheumatology (Oxford). 2000; 39: 110-2.
52. Bando H, Kobayashi S, Matsumoto T, et al. Acute acalculous cholecystitis induced by mesenteric inflammatory veno-occlusive disease (MIVOD) in systemic lupus erythematosus. Clin Rheumatol. 2003; 22:447-9.
53. Dessailboud R, Papo T, Vaneecloo S, Gamblin C, Vanhille P, Piette JC. Acalculous ischemic gallbladder necrosis in the catastrophic antiphospholipid syndrome. Arthritis Rheum. 1998; 41:1318-20.
54. Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol. 2004; 31:707-12.
55. Derk CT, DeHoratius RJ. Systemic lupus erythematosus and acute pancreatitis: a case series. Clin Rheumatol. 2004; 23:147-51.
56. Saab S, Corr MP, Weisman MH. Corticosteroids and systemic lupus erythematosus pancreatitis: a case series. J Rheumatol. 1998; 25:801-6.
57. Kolk A, Horneff G, Wilgenbus KK, Wahn V, Gerharz CD. Acute lethal necrotising pancreatitis in childhood systemic lupus erythematosus - possible toxicity of immunosuppressive therapy. Clin Exp Rheumatol. 1995; 13:399-403.
58. Nesher G, Breuer GS, Temprano K, Moore TL, Dahan D, Baer A, Alberton J, Izbicki G, Hersch M. Lupus-associated pancreatitis. Semin Arthritis Rheum. 2006 Feb;35(4):260-7.
59. Tsao CH, Chen CY, Ou LS, Huang JL. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J Rheumatol. 2002; 29:1214-8.
60. Pablos JL, Aragon A, Gomez-Reino JJ. Salmonellosis and systemic lupus erythematosus. Report of ten cases. Br J Rheumatol. 1994; 33:129-32.
61. Tai ES, Fong KY. Fatal amoebic colitis in a patient with SLE: a case report and review of the literature. Lupus. 1997; 6:610-2.
62. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997; 40:761-8
63. Nived O, Bengtsson A, Jonsen A, Sturfelt G, Olsson H. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus. 2001; 10:500-4.
64. Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992; 51:437-9.
65. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005; 52:1481-90.
66. Ikura Y, Nagatomi N, Ohtani K, et al. Autopsy case of hepatocellular carcinoma associated with lupoid hepatitis and complicated by malignant lymphoma. Gastroenterol Jpn. 1993; 28:564-9.
67. Sakaguchi T, Nakamura S, Suzuki S, et al. Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports. Surg Today. 1995; 25:838-42.
68. Freundlich B, Makover D, Maul GG. A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Ann Intern Med. 1988; 109:295-7.
69. Kraus A, Garza-Elizondo MA, Diaz-Jouanen E. A multisystemic disease (lupus-like) preceding bronchioloalveolar carcinoma. Clin Rheumatol. 1985; 4:192-5.
70. Solans-Laque R, Perez-Bocanegra C, Salud-Salvia A, et al. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus. 2004; 13:159-64.
71. Gibson T, Myers AR. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol. 1981; 8:752-9.
72. Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus. Q J Med. 1984; 53:401-9.
73. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med. 1980; 69:187-94.
74. van Hoek B. The spectrum of liver disease in systemic lupus erythematosus. Neth J Med. 1996; 48:244-53.
75. Van Steenbergen W, Beyls J, Vermylen J, et al. 'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. J Hepatol. 1986; 3:87-94.
76. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis. 2004; 63:123-9.
77. Arnett FC, Reichlin M. Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med. 1995; 99:465-72.
78. Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW. How lupoid is lupoid hepatitis? J Rheumatol. 1986; 13:95-8.
79. Matsumoto T, Yoshimine T, Shimouchi K, et al. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol. 1992; 23:1151-8
80. Mok CC. Investigations and management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2005; 19:741-66.